EVO
Evotec SE American Depositary Shares
Pharmaceutical Preparations
Best Pharmaceutical Stocks 2026 →
Evotec (EVO) Stock: Buy, Sell, or Hold?
$1.69
+0.00 (+0.00%)
▲
5d:
+7.64%
30d:
+25.65%
90d:
-16.34%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (29%)
Quality Score
23/100
Position
EXTENDED
30-Day Fair Range
$1.44 – $1.66
Position: EXTENDED
Forward P/E & Valuation
21.1x
CHEAP
vs 25.6x historical avg
Wall Street Target
$4.52
+167.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.50 / $1.82
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: EVO shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When EVO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: EVO is currently trading at $1.69, which is considered extended relative to its 30-day fair value range of $1.44 to $1.66. From a valuation perspective, the stock is trading at a discount (Forward PE: 21.1) compared to its historical average (25.6). Remarkably, the market is currently pricing in an annual earnings decline of 6.2% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, EVO is in a strong downtrend. Immediate support is located at $1.50, while resistance sits at $1.82.
Market Sentiment: EVO scores 8/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $4.52 (+167.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, EVO is in a strong downtrend. Immediate support is located at $1.50, while resistance sits at $1.82.
Market Sentiment: EVO scores 8/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $4.52 (+167.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.44 -
$1.66
Company Quality Score
23/100
(STRONG SELL)
Volume Confirmation
HIGH
Confidence Score
28.6%
Trading Range & Key Levels
30-Day Trading Range
$1.44 -
$1.66
Current vs Trading Range
EXTENDED
Support Level
$1.50
Resistance Level
$1.82
Current Trend
Strong Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (8/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 167.7% below Wall St target ($4.52)
- WARNING: Composite score 23/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
21.12
Wall Street Target
$4.52
(+167.7%)
Revenue Growth (YoY)
0.6%
Profit Margin
-25.2%
Valuation Discount vs History
-6.2% cheaper
PE vs Historical
21.1 vs 25.6
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-6.2%
(market-implied from PE analysis)
1-Year Target
$1.59
(-6%)
2-Year Target
$1.49
(-12%)
3-Year Target
$1.39
(-18%)
3-Yr Target (if PE normalizes)
(PE: 21→26)
$1.69
(0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 21.1 to 25.6
Stabilization Target:
$2.05
(+21.2%)
PE Expansion Potential:
+21.2%
Share EVO Analysis
Share this live EVO analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (EVO)
Bullish
1 Retail Mentions
Reddit / WSB Comments
1
Bullish
Last Tracked
Oct 31, 2026
Daily AI digest
AI Retail Discussion Summary:
Reddit & WallStreetBets discussions on EVO are bullish (sentiment score +0.49) across 1 tracked comments.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 8:00 PM ET
Data refreshes hourly during market hours. Next update: 9:00 PM
Data refreshes hourly during market hours. Next update: 9:00 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EVO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
29 analysts |
$208 | 23 SELL |
|
ALKS
Alkermes Plc |
STRONG BUY
20 analysts |
$58 | 33 SELL |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 62 BUY |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$687 | 52 HOLD |
|
HROW
Harrow Health Inc |
STRONG BUY
9 analysts |
$63 | 53 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive EVO Research Pages
